Log In Get Started
Stock Markets March 20, 2026

Prestige Consumer to acquire Breathe Right in $1.045 billion transaction

Deal expands Prestige into nasal care with a brand reporting $200 million revenue and $95 million core profit in 2025

By Ajmal Hussain PBH
Prestige Consumer to acquire Breathe Right in $1.045 billion transaction
PBH

Prestige Consumer Healthcare will purchase the Breathe Right brand and related assets from Foundation Consumer Healthcare for $1.045 billion, a figure that falls to about $900 million after tax benefits. The acquisition, which is expected to close in the first half of 2027, brings a brand that generated roughly $200 million in revenue and $95 million in core profit in 2025 into Prestige’s portfolio and is projected to be accretive to the company’s core profit.

Key Points

  • Prestige will acquire Breathe Right and related assets for $1.045 billion, a figure that falls to about $900 million after tax benefits.
  • Breathe Right generated about $200 million in revenue and $95 million in core profit in 2025 and will become the largest brand in Prestige's portfolio.
  • The transaction is expected to close in the first half of 2027 and to be accretive to Prestige's core profit; Prestige recently beat third-quarter revenue estimates.

Prestige Consumer Healthcare said on Friday it has reached an agreement to buy the Breathe Right brand and related assets from Foundation Consumer Healthcare in a transaction valued at $1.045 billion. After accounting for tax benefits, Prestige characterized the effective value of the deal at about $900 million.

The acquisition brings Breathe Right, a widely distributed nasal strip brand, into Prestige’s product lineup. The deal will mark Prestige’s entry into a new product category and is expected to make Breathe Right the largest brand in its portfolio. According to the company, Breathe Right produced approximately $200 million in revenue and $95 million in core profit in 2025.

Prestige’s leadership framed the move as consistent with its acquisition strategy. "Today’s acquisition fits squarely within our disciplined M&A framework and the Breathe Right brand enhances our portfolio over the long-term," said Prestige CEO Ron Lombardi.

The transaction is slated to close during the first half of 2027. Prestige indicated the purchase should be accretive to its core profit, and noted it recently exceeded third-quarter revenue estimates on Thursday.

Prestige develops and distributes over-the-counter health and personal care products across North America, Australia and other global markets. The company said the addition of Breathe Right aligns with its efforts to grow and diversify its portfolio within consumer health.

Alongside the company announcement, the article referenced ProPicks AI, which evaluates PBH alongside thousands of other companies each month using more than 100 financial metrics. ProPicks AI, described as an AI-driven stock idea engine in the announcement, assesses fundamentals, momentum, and valuation and cited historical winners including Super Micro Computer (+185%) and AppLovin (+157%). The promotional language asked whether PBH is currently featured in any ProPicks AI strategies or if other opportunities exist in the same sector.

Summary of the deal

  • Purchase price: $1.045 billion; approximately $900 million after tax benefits.
  • Breathe Right 2025 performance: about $200 million revenue and $95 million core profit.
  • Closing timeframe: expected in the first half of 2027; deal expected to be accretive to core profit.

Risks

  • Closing timeline uncertainty - the transaction is expected to close during the first half of 2027, creating a period before deal completion in which outcomes could change.
  • Integration and category expansion - the acquisition moves Prestige into a new product category, which carries execution risk for market and distribution integration.
  • Financial assumptions - the stated post-tax effective deal value depends on projected tax benefits, which could affect the net cost if those benefits differ from expectations.

More from Stock Markets

Evercore Sees Supply Shock Boosting U.S. Onshore Oilfield Services; Upgrades Halliburton and Helmerich & Payne Mar 20, 2026 Market Movers: Mega-Cap Declines Contrast With Select Mid- and Small-Cap Gains Mar 20, 2026 Texas Capital Starts Coverage of Strategy Inc, Backs Bitcoin-Accumulation Plan Mar 20, 2026 Janus Henderson Shares Slip After Trian Rejects Victory Capital’s Revised Offer Mar 20, 2026 Nvidia to Supply One Million GPUs to AWS Across Multi-Year Agreement Mar 20, 2026